trial · primary record
SYS6062
Advanced Solid Tumors
| Phase | Phase 1, Phase 2 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 260 |
| Primary completion | 2029-11-01 |
| Primary endpoint | Adverse events (AEs) and serious adverse events (SAEs) |
| Registry ID | NCT07897227 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-28T02:32:15.045Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT07897227
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.